Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pre-heparin lipoprotein lipase mass.

Junji Kobayashi1

  • 1Department of Lifestyle-related Disease, Kanazawa University Graduate School of Medical Science, Takara-machi, Japan. junji@med.kanazawa-u.ac.jp

Journal of Atherosclerosis and Thrombosis
|April 7, 2004
PubMed
Summary

Measuring lipoprotein lipase (LPL) mass before heparin injection offers valuable insights into metabolic disorders and inflammation. This pre-heparin LPL mass correlates with key health markers, aiding in understanding disease pathophysiology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful long-term remission of hyperchylomicronemia caused by GPIHBP1 autoantibodies: With insights into antibody epitope effects.

Journal of clinical lipidology·2026
Same author

Severe HDL-C Deficiency Caused by Acquired LCAT Deficiency: A Case Report with Lipidomic Profiling and Anti-LCAT Autoantibody Detection.

Internal medicine (Tokyo, Japan)·2026
Same author

A large-scale visual survey of beef carcass lean and fat colors for digital beef quality management.

Meat science·2026
Same author

Little Evidence of Atherosclerosis in a Middle-aged Japanese Woman with Familial Hypercholesterolemia Carrying PCSK9 (p.Glu32Lys) and ABCG8 (p.Ile419Asn) Variants despite Elevated Lipoprotein (a) Levels.

Internal medicine (Tokyo, Japan)·2025
Same author

Exploring the association between self-efficacy for locomotor function and diabetes status in older females: a pilot study.

Diabetology international·2025
Same author

Efficacy and safety of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide in Japanese patients with type 2 diabetes mellitus.

Diabetology international·2024

Area of Science:

  • Biochemistry
  • Metabolic Disorders
  • Clinical Diagnostics

Background:

  • Lipoprotein lipase (LPL) is crucial for triglyceride hydrolysis in lipoproteins.
  • Measuring LPL mass without heparin has gained clinical interest beyond rare disorders.
  • Pre-heparin LPL mass shows associations with metabolic and inflammatory markers.

Purpose of the Study:

  • To explore the clinical significance of pre-heparin plasma LPL mass.
  • To investigate the relationship between pre-heparin LPL mass and metabolic parameters.
  • To assess the utility of pre-heparin LPL mass as a marker for metabolic disorders and inflammation.

Main Methods:

  • Measurement of LPL mass in pre-heparin plasma samples.
  • Correlation analysis with serum lipids, lipoproteins, and visceral fat area.

Related Experiment Videos

  • Evaluation as a potential marker for acute inflammation.

    • Main Results:

    • Pre-heparin LPL mass correlates significantly with serum lipid profiles and lipoproteins.
    • Visceral fat area shows a significant relationship with pre-heparin LPL mass.
    • Pre-heparin LPL mass may serve as a surrogate marker for acute inflammation.

    Conclusions:

    • Pre-heparin LPL mass provides clinically relevant information on metabolic disorders.
    • This simple measurement offers insights into the pathophysiology of inflammation.
    • Pre-heparin LPL mass is a valuable, practical marker for metabolic health assessment.